Ana Marisa Chudzinski-Tavassi

Ana Marisa Chudzinski-Tavassi

Center of Excellence in New Target Discovery, Butantan Institute

Affiliated withButantan Institute

Research Area

Biography

Ana Marisa Chudzinski-Tavassi has not added Biography.
If you are Ana Marisa Chudzinski-Tavassi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Publication title

Cited by 1

2025

Other Publications

Article
Year
A prothrombin activator (Lopap) modulating inflammation, coagulation and cell survival mechanisms.

Biochemical and biophysical research communications| PubMed ID: 15963468

2005
Protein mapping of the salivary complex from a hematophagous leech.

Omics : a journal of integrative biology| PubMed ID: 15969650

2005
Releasing or expression modulating mediator involved in hemostasis by Berythractivase and Jararhagin (SVMPs).

Toxicon : official journal of the International Society on Toxinology| PubMed ID: 16626772

2006
Exploring new molecules and activities from Lonomia obliqua caterpillars.

Pathophysiology of haemostasis and thrombosis| PubMed ID: 16707933

2005
The venom of the Lonomia caterpillar: an overview.

Toxicon : official journal of the International Society on Toxinology| PubMed ID: 17320134

2007
2010
Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro".

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie| PubMed ID: 22281290

2012
2012
2012
A Kunitz-type FXa inhibitor affects tumor progression, hypercoagulable state and triggers apoptosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie| PubMed ID: 23433900

2013
2013
2015
2016
Tick salivary gland as potential natural source for the discovery of promising antitumor drug candidates.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie| PubMed ID: 26796259

2016
Harnessing the knowledge of animal toxins to generate drugs.

Pharmacological research| PubMed ID: 26826284

2016
2016
2016
Hemolin triggers cell survival on fibroblasts in response to serum deprivation by inhibition of apoptosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie| PubMed ID: 27470394

2016
2016
2016
Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar .

The journal of venomous animals and toxins including tropical diseases| PubMed ID: 28031734

2016
2017
2018
A Combined Computer-Aided Approach to Drive the Identification of Potential Epitopes in Protein Therapeutics.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques| PubMed ID: 30011260

2018
Biodistribution and Pharmacokinetics of Amblyomin-X, a Novel Antitumour Protein Drug in Healthy Mice.

European journal of drug metabolism and pharmacokinetics| PubMed ID: 30132264

2019
2020
2018
2019
2019
2019
Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.

International journal of molecular sciences| PubMed ID: 32283739

2020
2020
2020
2021
Envenoming and Innovative Research.

Toxins| PubMed ID: 34941670

2021
2021
2021
2022
2022
2022
2022
2022
2022
2022
2023
2024
2024
2024
2025
2025